University of Minnesota professor of medicine and endocrinologist Elizabeth Seaquist, M.D., was recently named President of Medicine and Science, on the Board of Directors for the American Diabetes Association, the nation’s largest voluntary health organization leading the fight to Stop Diabetes®.
As President of Medicine and Science, Seaquist will serve as the co-principal spokesperson with the President, Health Care and Education of the Association on science, health care and educational matters, and will assist with oversight of the Association’s business affairs. Additionally, she will work closely with the Association’s volunteers and staff on activities and initiatives in support of the organization’s mission during her tenure.
“As a researcher and clinician, my professional goal has been to improve the lives of people with diabetes,” said Seaquist. “As the President of Medicine and Science, I will be able to advance this goal on a national and international basis. I look forward to serving people with diabetes as an Association leader.”
Seaquist has been a member of the American Diabetes Association since 1987 and has served at the national level on the Research Policy Committee, the Research Grant Review Committee and the Scientific Sessions Meeting Planning Committee. She currently serves on the editorial board for Diabetes Care. At the local level, she served a two-year term as co-chair of the American Diabetes Association EXPO in her home city of Minneapolis and leads a successful Tour de Cure team.
Seaquist is a clinical investigator interested in the complications of diabetes. She was awarded a Distinguished Clinical Scientist Award by the American Diabetes Association in 2009. Her research focuses on the effect of diabetes on brain metabolism, structure and function. She also directs the University of Minnesota site for two NIH-funded clinical trials, including the GRADE study that is currently enrolling patients with newly diagnosed type 2 diabetes into a study that will determine the best drug to add to a metformin-based regimen (http://grade.bsc.gwu.edu or firstname.lastname@example.org).
Seaquist is also the principal investigator on the NIH training grant for fellows in endocrinology and diabetes at the University of Minnesota, and maintains an active clinical practice. Seaquist also holds the Pennock Family Chair in Diabetes Research at the University, and was a 2012 recipient of the Medical Alumni Society’s Distinguished Alumni Award.